Incidence of vasa praevia: a systematic review and meta-analysis

Weiyu Zhang, Tara Giacchino, Pannapat Amy Chanyarungrojn, Olivia Ionescu, Ranjit Akolekar, Weiyu Zhang, Tara Giacchino, Pannapat Amy Chanyarungrojn, Olivia Ionescu, Ranjit Akolekar

Abstract

Objectives: To derive accurate estimates of the incidence of vasa praevia (VP) in a routine population of unselected pregnancies.

Design: Systematic review and meta-analysis.

Data sources: A search of MEDLINE, EMBASE, CINAHL and the Cochrane database was performed to review relevant citations reporting outcomes in pregnancies with VP from January 2000 until 5 April 2023.

Eligibility criteria for selection of studies: Prospective or retrospective cohort or population studies that provided data regarding VP cases in routine unselected pregnancies during the study period. We included studies published in the English language after the year 2000 to reflect contemporary obstetric and neonatal practice.

Data extraction and synthesis: Two reviewers independently screened the retrieved citations and extracted data. The methodological quality of studies was assessed using the Newcastle-Ottawa Scale, and Preferred Reporting Items for Systematic reviews and Meta-Analyses was used to ensure standardised reporting of studies.

Results: A total of 3847 citations were screened and 82 full-text manuscripts were retrieved for analysis. There were 24 studies that met the inclusion criteria, of which 12 studies reported prenatal diagnosis with a systematic protocol of screening. There were 1320 pregnancies with VP in a total population of 2 278 561 pregnancies; the weighted pooled incidence of VP was 0.79 (95% CI: 0.59 to 1.01) per 1000 pregnancies, corresponding to 1 case of VP per 1271 (95% CI: 990 to 1692) pregnancies. Nested subanalysis of studies reporting screening for VP based on a specific protocol identified 395 pregnancies with VP in a population of 732 654 pregnancies with weighted pooled incidence of 0.82 (95% CI: 0.53 to 1.18) per 1000 pregnancies (1 case of VP per 1218 (95% CI: 847 to 1901) pregnancies).

Conclusion: The incidence of VP in unselected pregnancies is 1 in 1218 pregnancies. This is higher than is previously reported and can be used as a basis to assess whether screening for this condition should be part of routine clinical practice. Incorporation of strategies to screen for VP in routine clinical practice is likely to prevent 5% of stillbirths.

Prospero registration number: CRD42020125495.

Keywords: Fetal medicine; Prenatal diagnosis; Systematic Review.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.

Figures

Figure 1
Figure 1
Flow chart demonstrating process of selection of studies included in the systematic review.
Figure 2
Figure 2
Forest plot demonstrating incidence of vasa praevia in studies reporting results of routine screening in low-risk unselected pregnancies. Incidence (%; 95% CIs) is reported as number of cases per 1000 pregnancies.

References

    1. McNair AJ. Placenta prævia, with vasa prævia; cæsarean section. Proc R Soc Med 1921;14(Obstet Gynaecol Sect):195–6.
    1. ALMENT EAJ. Vasa praevia simulating antepartum haemorrhage. Br Med J 1949;2:. 10.1136/bmj.2.4639.1273
    1. Sinkey RG, Odibo AO, Dashe JS. Diagnosis and management of vasa previa. society of maternal-fetal (SMFM) publications committee. Am J Obstet Gynecol 2015;213:615–9. 10.1016/j.ajog.2015.08.031
    1. Oyelese KO, Turner M, Lees C, et al. . Vasa Previa: an avoidable obstetric tragedy. Obstet Gynecol Surv 1999;54:138–45. 10.1097/00006254-199902000-00024
    1. Catanzarite V, Oyelese Y. Diagnosis and management of vasa previa. Am J Obstet Gynecol 2016;214:764. 10.1016/j.ajog.2016.02.012
    1. Robert JA, Sepulveda W. Fetal exsanguination from ruptured vasa previa: still a catastrophic event in modern obstetrics. J Obstet Gynaecol 2003;23:574. 10.1080/0144361031000156636
    1. Antoine C, Young BK, Silverman F, et al. . Sinusoidal fetal heart rate pattern with vasa previa in twin pregnancy. J Reprod Med 1982;27:295–300.
    1. Catanzarite V, Maida C, Thomas W, et al. . Prenatal sonographic diagnosis of vasa previa: ultrasound findings and obstetric outcome in ten cases. Ultrasound Obstet Gynecol 2001;18:109–15. 10.1046/j.1469-0705.2001.00448.x
    1. Oyelese Y, Catanzarite V, Prefumo F, et al. . Vasa previa: the impact of prenatal diagnosis on outcomes. Obstet Gynecol 2004;103(5 Pt 1):937–42. 10.1097/01.AOG.0000123245.48645.98
    1. Catanzarite V, Cousins L, Daneshmand S, et al. . Prenatally diagnosed vasa previa: a single-institution series of 96 cases. Obstet Gynecol 2016;128:1153–61. 10.1097/AOG.0000000000001680
    1. Sullivan EA, Javid N, Duncombe G, et al. . Vasa previa diagnosis, clinical practice, and outcomes in Australia. Obstet Gynecol 2017;130:591–8. 10.1097/AOG.0000000000002198
    1. Zhang W, Geris S, Beta J, et al. . Prevention of stillbirth: impact of two-stage screening for vasa previa. Ultrasound Obstet Gynecol 2020;55:605–12. 10.1002/uog.21953
    1. Zhang W, Geris S, Al-Emara N, et al. . Perinatal survival in pregnancies with a prenatal diagnosis of vasa praevia: a systematic review and meta-analysis. Ultrasound Obstet Gynecol 2021;57:710–9. 10.1002/uog.22166
    1. Jauniaux E, Alfirevic Z, Bhide AG, et al. . Vasa praevia: diagnosis and management: green-top guideline No.27B. BJOG 2019;126:e49–61. 10.1111/1471-0528.15307
    1. Screening for vasa praevia: an evidence map to outline the volume and type of evidence related to screening for vasa praevia for the UK National Screening Committee: version 1.1: Costello Medical: UK National Screening Committee. 2023Available: [Accessed 28 Apr 2023].
    1. Ruiter L, Kok N, Limpens J, et al. . Incidence of and risk indicators for vasa praevia: a systematic review. BJOG 2016;123:1278–87. 10.1111/1471-0528.13829
    1. NHS Centre for Reviews and Dissemination . Systematic reviews: CRD’s guidance for undertaking reviews in health care. York, UK: University of York, 2009.
    1. Wells GA, Shea B, O’Connell D, et al. . The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis, Available:
    1. Moher D, Liberati A, Tetzlaff J, et al. . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535. 10.1136/bmj.b2535
    1. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177–88. 10.1016/0197-2456(86)90046-2
    1. Office for National Statistics . Births in England and Wales: summary tables: August 2022. Available: [Accessed 28 Apr 2023].
    1. Vital events reference tables . National records of Scotland. 2022. Available: [Accessed 28 Apr 2023].
    1. Northern Ireland Statistics and Research Agency . Stillbirth and Infant Death Numbers. 2022Available: [Accessed 28 Apr 2023].
    1. Lee W, Lee VL, Kirk JS, et al. . Vasa Previa: prenatal diagnosis, natural evolution, and clinical outcome. Obstet Gynecol 2000;95:572–6. 10.1016/s0029-7844(99)00600-6
    1. Schachter M, Tovbin Y, Arieli S, et al. . In vitro fertilisation is a risk factor for vasa praevia. Fertil Steril 2002;78:642–3. 10.1016/S0015-0282(02)03253-3
    1. Baulies S, Maiz N, Muñoz A, et al. . Prenatal ultrasound diagnosis of vasa praevia and analysis of risk factors. Prenat Diagn 2007;27:595–9. 10.1002/pd.1753
    1. Suzuki S, Igarashi M. Clinical significance of pregnancies with succenturiate lobes of placenta. Arch Gynecol Obstet 2008;277:299–301. 10.1007/s00404-007-0482-6
    1. Smorgick N, Tovbin Y, Ushakov F, et al. . Is neonatal risk from vasa previa preventable? the 20-year experience from a single medical center. J Clin Ultrasound 2010;38:118–22. 10.1002/jcu.20665
    1. Hasegawa J, Farina A, Nakamura M, et al. . Analysis of the ultrasonographic findings predictive of vasa Previa. Prenat Diagn 2010;30:1121–5. 10.1002/pd.2618
    1. Kanda E, Matsuda Y, Kamitomo M, et al. . Prenatal diagnosis and management of vasa previa: a 6-year review. J Obstet Gynaecol Res 2011;37:1391–6. 10.1111/j.1447-0756.2011.01544.x
    1. Rebarber A, Dolin C, Fox NS, et al. . Natural history of vasa previa across gestation using a screening protocol. J Ultrasound Med 2014;33:141–7. 10.7863/ultra.33.1.141
    1. Bronsteen R, Whitten A, Balasubramanian M, et al. . Vasa previa: clinical presentations, outcomes, and implications for management. Obstet Gynecol 2013;122(2 Pt 1):352–7. 10.1097/AOG.0b013e31829cac58
    1. Hasegawa J, Arakaki T, Ichizuka K, et al. . Management of vasa previa during pregnancy. J Perinat Med 2015;43:783–4. 10.1515/jpm-2014-0047
    1. Kulkarni A, Powel J, Aziz M, et al. . Vasa previa: prenatal diagnosis and outcomes: thirty-five cases from a single maternal-fetal medicine practice. J Ultrasound Med 2018;37:1017–24. 10.1002/jum.14452
    1. Nohuz E, Boulay E, Gallot D, et al. . Can we perform a prenatal diagnosis of vasa previa to improve its obstetrical and neonatal outcomes J Gynecol Obstet Hum 2017;46:373–7. 10.1016/j.jogoh.2017.02.009
    1. Yeaton-Massey A, Girsen AI, Mayo JA, et al. . Vasa previa and extreme prematurity: a population-based study. J Perinatol 2019;39:475–80. 10.1038/s41372-019-0319-8
    1. Derisbourg S, Boulay A, Lamy C, et al. . First trimester ultrasound prediction of velamentous cord insertions: a prospective study. J Matern Fetal Neonatal Med 2021;34:2642–8. 10.1080/14767058.2019.1670797
    1. Klahr R, Fox NS, Zafman K, et al. . Frequency of spontaneous resolution of vasa Previa with advancing gestational age. Am J Obstet Gynecol 2019;221:646. 10.1016/j.ajog.2019.06.040
    1. La S, Melov SJ, Nayyar R. Are we over-diagnosing vasa praevia? the experience and lessons learned in a tertiary centre. Aust N Z J Obstet Gynaecol 2021;61:217–22. 10.1111/ajo.13259
    1. Gross A, Markota Ajd B, Specht C, et al. . Systematic screening for vasa previa at the 20-week anomaly scan. Acta Obstet Gynecol Scand 2021;100:1694–9. 10.1111/aogs.14205
    1. Sutera M, Garofalo A, Pilloni E, et al. . Vasa previa: when antenatal diagnosis can change fetal prognosis. J Perinat Med 2021;49:915–22. 10.1515/jpm-2020-0559
    1. Liu N, Hu Q, Liao H, et al. . Vasa previa: perinatal outcomes in singleton and multiple pregnancies. Biosci Trends 2021;15:118–25. 10.5582/bst.2021.01052
    1. Kamijo K, Miyamoto T, Ando H, et al. . Clinical characteristics of a novel "type 3" vasa Previa: case series at a single center. J Matern Fetal Neonatal Med 2022;35:7730–6. 10.1080/14767058.2021.1960975

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner